Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial

Documenti analoghi

• Can serum L-lactate, D-lactate, creatine kinase and I-FABP be used as diagnostic markers in critically ill patients suspected for bowel ischemia
  di: van der Voort, Peter HJ, et al.
  Pubblicazione: (2014)
• Accuracy of Intra-arterial and Subcutaneous Continuous Glucose Monitoring in Postoperative Cardiac Surgery Patients in the ICU
  di: Sechterberger, Marjolein K., et al.
  Pubblicazione: (2014)
• The ecological effects of selective decontamination of the digestive tract (SDD) on antimicrobial resistance: a 21-year longitudinal single-centre study
  di: Buitinck, Sophie, et al.
  Pubblicazione: (2019)
• The association of intravenous insulin and glucose infusion with intensive care unit and hospital mortality: a retrospective study
  di: van Steen, Sigrid C., et al.
  Pubblicazione: (2019)
• The association between lactate, mean arterial pressure, central venous oxygen saturation and peripheral temperature and mortality in severe sepsis: a retrospective cohort analysis
  di: Houwink, Aletta P. I., et al.
  Pubblicazione: (2016)